Jean F. Voltaire

Array ( [id] => 7122897 [patent_doc_number] => 20050014726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol' [patent_app_type] => utility [patent_app_number] => 10/493042 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9689 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014726.pdf [firstpage_image] =>[orig_patent_app_number] => 10493042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7215421 [patent_doc_number] => 20050054555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Kahalalide compounds for use in cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/492670 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6402 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054555.pdf [firstpage_image] =>[orig_patent_app_number] => 10492670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7123002 [patent_doc_number] => 20050014831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Use of hydroxyoleic acid and similar compounds in the production of medicaments' [patent_app_type] => utility [patent_app_number] => 10/488726 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5776 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014831.pdf [firstpage_image] =>[orig_patent_app_number] => 10488726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856837 [patent_doc_number] => 20030130338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Method of treatment' [patent_app_type] => new [patent_app_number] => 10/256420 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1575 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130338.pdf [firstpage_image] =>[orig_patent_app_number] => 10256420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6673881 [patent_doc_number] => 20030059484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Cosmetic treatment method for fighting against skin ageing effects' [patent_app_type] => new [patent_app_number] => 10/244741 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3736 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059484.pdf [firstpage_image] =>[orig_patent_app_number] => 10244741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7156592 [patent_doc_number] => 20050026995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Injectable composition of paclitaxel' [patent_app_type] => utility [patent_app_number] => 10/489224 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5158 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026995.pdf [firstpage_image] =>[orig_patent_app_number] => 10489224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311117 [patent_doc_number] => 07528141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Use of cyclopenta[g]quinazoline derivatives for treating cancer' [patent_app_type] => utility [patent_app_number] => 10/487874 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13834 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528141.pdf [firstpage_image] =>[orig_patent_app_number] => 10487874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439612 [patent_doc_number] => 07259188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators' [patent_app_type] => utility [patent_app_number] => 10/229649 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6119 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259188.pdf [firstpage_image] =>[orig_patent_app_number] => 10229649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721346 [patent_doc_number] => 20030055036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Method for treating a demyelinating condition' [patent_app_type] => new [patent_app_number] => 10/223068 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10061 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055036.pdf [firstpage_image] =>[orig_patent_app_number] => 10223068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770470 [patent_doc_number] => 20030216410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Combination therapy for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/218910 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69841 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216410.pdf [firstpage_image] =>[orig_patent_app_number] => 10218910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696457 [patent_doc_number] => 20030108651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof' [patent_app_type] => new [patent_app_number] => 10/190043 [patent_app_country] => US [patent_app_date] => 2002-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7629 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108651.pdf [firstpage_image] =>[orig_patent_app_number] => 10190043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825653 [patent_doc_number] => 20030236275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Treatment methods of nasal congestion and nasal obstruction' [patent_app_type] => new [patent_app_number] => 10/177366 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3424 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236275.pdf [firstpage_image] =>[orig_patent_app_number] => 10177366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 672229 [patent_doc_number] => 07091241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-15 [patent_title] => 'Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined vitamins C and K3' [patent_app_type] => utility [patent_app_number] => 10/160152 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5753 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/091/07091241.pdf [firstpage_image] =>[orig_patent_app_number] => 10160152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306332 [patent_doc_number] => 20040116468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Therapeutic agent for glomerular disease' [patent_app_type] => new [patent_app_number] => 10/474194 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3050 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116468.pdf [firstpage_image] =>[orig_patent_app_number] => 10474194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583882 [patent_doc_number] => 07851461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Combination dosage of a cyclooxygenase (COX) inhibitor, a vitamin D3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer' [patent_app_type] => utility [patent_app_number] => 10/474058 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13114 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851461.pdf [firstpage_image] =>[orig_patent_app_number] => 10474058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913029 [patent_doc_number] => 20050176787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth' [patent_app_type] => utility [patent_app_number] => 10/474443 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2480 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176787.pdf [firstpage_image] =>[orig_patent_app_number] => 10474443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177656 [patent_doc_number] => 20020155999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/104896 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3843 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155999.pdf [firstpage_image] =>[orig_patent_app_number] => 10104896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474444 [patent_doc_number] => 20020151563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth' [patent_app_type] => new [patent_app_number] => 10/103251 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12322 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151563.pdf [firstpage_image] =>[orig_patent_app_number] => 10103251 [rel_patent_id] =>[rel_patent_doc_number] =>)